Biopharma | May 13, 2026
Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
NEJM study shows strong protection across strains
Hair care & quick commerce shine
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Subscribe To Our Newsletter & Stay Updated
